Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The redundant factor method and bladder cancer mortality

J C Barrett

    Journal of Epidemiology and Community Health
    |December 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide Images.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
    Same author

    Enhanced patient selection with quantitative continuous scoring of PD-L1 expression for IO treatment in metastatic NSCLC.

    NPJ precision oncology·2025
    Same author

    Analysis of mutation status and homologous recombination deficiency in tumors of patients with germline BRCA1 or BRCA2 mutations and metastatic breast cancer: OlympiAD.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer.

    Oncoimmunology·2019
    Same author

    Rare-Variant Studies to Complement Genome-Wide Association Studies.

    Annual review of genomics and human genetics·2018
    Same journal

    Comparative social costs of six early years disadvantages: a birth cohort microsimulation study.

    Journal of epidemiology and community health·2026
    Same journal

    Sociodemographic inequalities in non-small cell lung cancer (NSCLC) novel treatments: a national population-based cohort study.

    Journal of epidemiology and community health·2026
    Same journal

    Secular trends in primary care utilisation for mental health problems: a Norwegian register-based population-wide study.

    Journal of epidemiology and community health·2026
    Same journal

    Guide to recent advances in difference-in-differences methodology for population health studies.

    Journal of epidemiology and community health·2026
    Same journal

    From early to fewer first births: ADHD and family formation among young adults.

    Journal of epidemiology and community health·2026
    Same journal

    10-year mortality among first-time mothers involved in family court care proceedings in England: cohort study using linked administrative hospital, mortality and family court records.

    Journal of epidemiology and community health·2026
    See all related articles

    This study analyzed bladder cancer mortality in England and Wales (1951-1970). Including age at death, epoch of death, and epoch of birth in mortality analysis is worthwhile despite redundancy.

    Area of Science:

    • Epidemiology
    • Biostatistics
    • Public Health

    Background:

    • Bladder cancer mortality trends require nuanced analysis.
    • Understanding demographic influences on mortality is crucial for public health.
    • Previous analyses may not have fully explored the interplay of birth and death epochs.

    Purpose of the Study:

    • To investigate the utility of including age at death, epoch of death, and epoch of birth in mortality analysis.
    • To apply this comprehensive approach to bladder cancer mortality data for England and Wales.
    • To assess the impact of potential redundancy among these demographic factors.

    Main Methods:

    • Mortality analysis incorporating three key demographic factors: age at death, epoch of death, and epoch of birth.
    • Application of the analytical procedure to historical mortality data.

    Related Experiment Videos

  • Examination of data constraints imposed by factor redundancy.

    • Main Results:

    • The inclusion of all three factors, despite apparent redundancy, provides valuable insights into mortality patterns.
    • Analysis of bladder cancer mortality in England and Wales (1951-1970) revealed specific trends related to the demographic factors.
    • The constraints imposed by redundancy were manageable and did not preclude meaningful analysis.

    Conclusions:

    • Including age at death, epoch of death, and epoch of birth in mortality analyses is recommended, even with overlapping information.
    • This approach enhances the understanding of bladder cancer mortality dynamics.
    • The findings support a more comprehensive demographic consideration in epidemiological studies.